Sorry!! The article you are trying to read is not available now.
Merck & Co. (NY: MRK)
57.24 USD  -0.53 (-0.92%)
Streaming Delayed Price  /  Updated: 1:58 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(MRK) Community Analysis from
April 23, 2014
(Jutia Group, 4/4/14)
[Business Wire] - Merck , known as MSD outside the United States and...(read more)
(Stock Blog Hub, 8/13/13)
In an attempt to boost shareholders’ value, Merck & Co. Inc. (MRK) – the N.J. based major drug manufacturer – entered into an agreement with The Goldman Sachs Group, Inc. (GS) to...(read more)
(Wealth Daily, 2/15/13)
Major biotech Merck (NYSE: MRK) has increased its investment promise for small biotech Lycera, a company researching autoimmune disease drugs...
Merck (MRK) Company Overview

Merck & Co. (NYSE:MRK) is one of the largest pharmaceutical companies in the world, producing a wide assortment of medications. The company bought Schering-Plough (SGP) in 2009 to become one of the three largest pharmaceutical companies.

Merck faces many of the challenges that face all pharmaceutical companies, including issues surrounding patent expiration and FDA approval. In addition, there is growing pressure in the US and abroad to lower the price of medication. [1]

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here